Haddad Mounia, Stewart Joshua, Xie Philip, Cheung Stephanie, Trout Aysha, Keating Derek, Parrella Alessandra, Lawrence Sherina, Rosenwaks Zev, Palermo Gianpiero D
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY, USA.
J Assist Reprod Genet. 2021 Jan;38(1):101-123. doi: 10.1007/s10815-020-01987-0. Epub 2020 Nov 6.
Intracytoplasmic sperm injection (ICSI) is the most widely utilized assisted reproductive technique (ART) worldwide. In this feature, we review the early assisted fertilization attempts that eventually led to the development of ICSI, and discuss its current utilization in cases of male and non-male factor infertility.
We researched the literature related to the development, indications, and current use of ICSI, such as sperm structural abnormalities, male genetic indications, surgically retrieved sperm, high sperm chromatin fragmentation, oocyte dysmorphism, and preimplantation genetic testing (PGT). We also describe the potential future applications of ICSI.
This review summarizes the early micromanipulation techniques that led to the inception of ICSI. We also explore its current indications, including non-male factor infertility, where its use is more controversial. Finally, we consider the benefits of future advancements in reproductive biology that may incorporate ICSI, such as in vitro spermatogenesis, neogametogenesis, and heritable genome editing.
The versatility, consistency, and reliability of ICSI have made it the most prevalently utilized ART procedure worldwide.
胞浆内单精子注射(ICSI)是全球应用最广泛的辅助生殖技术(ART)。在本专题中,我们回顾了最终促成ICSI发展的早期辅助受精尝试,并讨论其在男性因素和非男性因素不孕症病例中的当前应用情况。
我们研究了与ICSI的发展、适应症和当前应用相关的文献,如精子结构异常、男性遗传适应症、手术获取的精子、高精子染色质碎片化、卵母细胞形态异常和植入前基因检测(PGT)。我们还描述了ICSI未来可能的应用。
本综述总结了促成ICSI诞生的早期显微操作技术。我们还探讨了其当前的适应症,包括非男性因素不孕症,其应用在此更具争议性。最后,我们考虑了生殖生物学未来进展可能带来的益处,这些进展可能会纳入ICSI,如体外精子发生、新配子发生和可遗传基因组编辑。
ICSI的多功能性、一致性和可靠性使其成为全球使用最普遍的ART程序。